Shares of Zydus Lifesciences rose 2 percent in early trade on March 14 after the company launched cancer drug Olaparib, a PARP inhibitor, under the brand name IBYRA in India. At 9:20am ...

Zydus Cadila launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both Early and Advanced HER2 positive Breast Cancer ...

Zydus Cadila gets USFDA nod to market generic cancer drug in US The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength ...